Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression?

Immunotherapy has shown great promise in treating various types of malignant tumors. However, some patients with gastrointestinal cancer have been known to experience rapid disease progression after treatment, a situation referred to as hyperprogressive disease (HPD). This minireview focuses on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mo-Xuan, Gao, Shu-Yue, Yang, Fan, Fan, Run-Jia, Yang, Qin-Na, Zhang, Tian-Lan, Qian, Nian-Song, Dai, Guang-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537503/
https://www.ncbi.nlm.nih.gov/pubmed/36212599
http://dx.doi.org/10.5306/wjco.v13.i9.729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537503/
https://www.ncbi.nlm.nih.gov/pubmed/36212599
http://dx.doi.org/10.5306/wjco.v13.i9.729

Ejemplares similares